XML 19 R3.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Revenues:        
Product revenues, net $ 74,535 $ 0 $ 74,535 $ 0
Royalty revenues 10,010 7,262 16,071 13,669
Collaborative revenues 29,879 24,360 97,480 40,382
Total revenues 114,424 31,622 188,086 54,051
Costs and expenses:        
Cost of product revenues 5,404 0 5,404 0
Royalty expenses 3,902 3,086 6,568 6,453
Research and development expenses 173,604 155,082 332,216 298,094
Sales, general and administrative expenses 96,663 40,915 168,186 76,467
Restructuring expense 741 2,112 1,501 2,892
Total costs and expenses 280,314 201,195 513,875 383,906
Loss from operations (165,890) (169,573) (325,789) (329,855)
Interest income 202 484 1,604 939
Interest expense (6,962) (3,683) (18,963) (7,638)
Change in fair value of derivative instruments (2,220) (27,234) (7,818) (28,723)
Loss before provision for income taxes (174,870) (200,006) (350,966) (365,277)
Provision for income taxes (Alios) 24,448   24,448  
Net loss (199,318) (200,006) (375,414) (365,277)
Net loss attributable to noncontrolling interest (Alios) (25,249) 0 (25,249) 0
Net loss attributable to Vertex $ (174,069) $ (200,006) $ (350,165) $ (365,277)
Basic net loss attributable to Vertex per common share (in dollars per share) $ (0.85) $ (1.00) $ (1.72) $ (1.83)
Diluted net loss attributable to Vertex per common share (in dollars per share) $ (0.85) $ (1.00) $ (1.72) $ (1.83)
Basic weighted-average number of common shares outstanding (in shares) 204,413 200,397 203,377 199,670
Diluted weighted-average number of common shares outstanding (in shares) 204,413 200,397 203,377 199,670